|
Post by marriott on Jun 14, 2021 12:52:44 GMT
When I would visit the National Research Institute office at Los Angeles to continue progress with the phase III trial , I would attempt to chat with anyone who would care to engage in a discussion concerning Novavax . I must admit not many that were shall we say as enthusiastic as I was . Yet none stated any adverse effects . That coupled with my actual results - absolutely no effects at all - gave me much confidence in the safety and efficacy of 2373 . Now the great results of PREVENT-19 results confirm what some of us believed. And praises to the entire Novavax team . Now it is time to focus exclusively on the gatekeepers throughout the global landscape. Time for the following individuals to rise and shine : Rick Crowley Executive Vice President, Chief Operations Officer John J. Trizzino Executive Vice President, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer Lyn Caltabiano, PhD Senior Vice President, Global Program Management Troy Morgan, JD Senior Vice President, Chief Compliance Officer Henrietta Ukwu, MD Senior Vice President, Chief Regulatory and Quality Officer The KEY to the marketplace is within our grasp !
|
|